Affinor Growers completes initial medical cannabis growth trial with 200% production increase
Vancouver (Canada), May 29, 2017 - Affinor Growers (CSE:AFI, OTC:RSSFF, Frankfurt:1AF) (“Affinor” or the “Corporation”), a diversified agriculture and biotechnology company with proprietary vertical farming systems, is pleased to announce the very positive results of the medical cannabis trial conducted in Mission BC.
Affinor is pleased to announce the cannabis trial and on-site test to grow medical marijuana in Mission BC has now been completed. The main objectives of the trial was to determine if cannabis plants could grow effectively on the vertical equipment, naturally in soil without the use of synthetic fertilizers or pesticide, as well as, develop specific growing protocol for quick maturing high density plants with multiple harvests per year.
The initial objectives were met with the single 4 level, 16 arm, vertical tower growing 256 cannabis plants in a little over 100 square feet from clone to harvest in seven weeks, under the license holder's growing license. The vertical growing tower was divided into different zones allowing several concurrent tests to identify ideal growing conditions and methods. A proprietary sequence of lighting, pruning techniques, nutritional formula coupled with a blended vegetative / flowering cycle resulted in optimal plant size and canopy density for the vertical growing equipment. Under these growing conditions, the newly developed crop model can produce up to 5 crops per year, as well as minimize the movement of the plants. Every plant was grown 100% organically with no synthetic fertilizers or pesticides.
Due to the various trials being conducted, final yields varied through the tower. However, one zone produced a reliable 15 to 20 grams per plant under a specific pruning, lighting and nutrient methods. Plans are already in motion to duplicate this protocol and build upon the developed crop model. As well, new LED lighting will be tested in parallel, creating the highest production intensity per square foot with low operating cost. Once achieved, Affinor's larger 10 level, 16 arm, tower capable of holding 640 plants in a little over 100 square feet, will be able to increase productivity over 200% when compared to 100 square feet of traditional indoor cannabis growing, for approximately half the utilities cost.
Jarrett Malnarick, President & CEO, comments, "We are very happy our initial growth trials and the product analysis proves the technology can grow cannabis organically in soil without the use of chemicals or pesticides. Medical cannabis can be a contaminated product, and we are excited to be changing the way cannabis will be commercially or personally produced. We look forward to working with our license holders to continue trials for cannabis and LED's to lower production cost and improve our proprietary crop models for high yielding, low cost, organic cannabis. We thank Mr. Sam Mellace for all his help and knowledge of the cannabis growth trial and look forward to additional improvements in the future."
Please follow our website under business development and social sites for details, pictures and future developments.
For More Information, please contact:
Jarrett Malnarick, President and CEO
About Affinor Growers Inc.
Affinor Growers is a publicly traded company on the Canadian Securities Exchange under the symbol ("AFI"). Affinor is focused on growing high quality crops such as romaine lettuce, spinach, and strawberries using its vertical farming techniques. Affinor is committed to becoming a pre-eminent supplier and grower, using exclusive vertical farming techniques.
On Behalf of the Board of Directors
AFFINOR GROWERS INC.
President & CEO
The CSE has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.
FORWARD LOOKING INFORMATION
This News Release contains forward-looking statements. The use of any of the words "anticipate", "continue", "estimate", "expect", "may", "will", "project", "should", "believe" and similar expressions are intended to identify forward-looking statements. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this News Release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company's disclosure documents which can be found under the Company's profile on HYPERLINK "http://www.sedar.com/"www.sedar.com. This News Release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.